National Development and Reform Commission to check drug cost or pave the way for drug price reform

The anti-monopoly investigation of foreign milk powder has not been stopped, and the national development and Reform Commission has started the cost investigation of drugs The national development and Reform Commission recently issued a notice saying that it has decided to investigate the cost and ex factory (port) price of some pharmaceutical enterprises In addition to a number of multinational pharmaceutical enterprises, Shuanglu pharmaceutical, humanwell pharmaceutical, Jinling pharmaceutical, Zhongsheng pharmaceutical and other listed companies are also listed As the first three rounds of drug price adjustment just ended, the market generally predicted that after this round of adjustment, the possibility of a significant adjustment of drug prices in the near future is less However, some analysts pointed out that this round of adjustment is intended to pave the way for the reform of drug price management mode Editor's comments: in recent years, drug price reduction policies have been frequently issued, but the effect is not ideal The public generally "did not feel", but brought side effects - many drugs, especially low-cost drugs, died as soon as they fell, and died as soon as they fell, which led to doubts about drug price management policies Therefore, it is very important to check the production and marketing costs of drugs, especially for some drugs with extremely high prices Only on the basis of fully understanding the cost and profit margin of drug manufacture and sale, can we make scientific and reasonable drug price Moreover, finding out the cost of drug production and marketing is the key to ensure the transparency of drug pricing The higher the transparency, the better the public's understanding and trust.